We highlight one such strategy, namely, the design of cell-penetrating dominant-negative decoy peptides that exploit the leucine zipper properties of ATF5 and/or CEBPB and CEBPD, and that selectively suppress the growth and survival of tumor cells. Here, CEBPB is linked to neoplasm.